Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
344561por Moon, Sohee, Kim, Sujin, Mankhong, Sakulrat, Choi, Seong Hye, Vandijck, Manu, Kostanjevecki, Vesna, Jeong, Jee Hyang, Yoon, Soo Jin, Park, Kyung Won, Kim, Eun-Joo, Yoon, Bora, Kim, Hee Jin, Jang, Jae-Won, Hong, Jin Yong, Park, Dong-Ho, Shaw, Leslie M., Kang, Ju-Hee“…BACKGROUND: Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker cutoffs from immunoassays with low interlaboratory variability in diverse ethnic groups are necessary for their use in clinics and clinical trials. With lack of cutoffs from fully automated immunoassay platforms in diverse races, the aim of this study is to evaluate the clinical utility of CSF AD biomarkers from the Lumipulse fully automated immunoassay based on β-amyloid (Aβ) positron emission tomography (PET) status comparing with these from two manual immunoassays, in Koreans. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344562por Cevik, Muge, Tate, Matthew, Lloyd, Ollie, Maraolo, Alberto Enrico, Schafers, Jenna, Ho, Antonia“…We included case series (with five or more participants), cohort studies, and randomised controlled trials that reported SARS-CoV-2, SARS-CoV, or MERS-CoV infection, and reported viral load kinetics, duration of viral shedding, or viable virus. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344563por McCoy, Rozalina G., Van Houten, Holly K., Deng, Yihong, Mandic, Pinar Karaca, Ross, Joseph S., Montori, Victor M., Shah, Nilay D.“…IMPORTANCE: Glucagonlike peptide-1 receptor agonists (GLP-1RA), sodium-glucose cotransporter-2 inhibitors (SGLT2i), and dipeptidyl peptidase-4 inhibitors (DPP-4i) are associated with low rates of hypoglycemia, and postmarketing trials of GLP-1RA and SGLT2i demonstrated that these medications improved cardiovascular and kidney outcomes. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344564por Drewnowski, Adam, Garrett, Greg S, Kansagra, Rishi, Khan, Noor, Kupka, Roland, Kurpad, Anura V, Mannar, Venkatesh, Martorell, Reynaldo, Zimmermann, Michael B“…There is a beneficial impact on hemoglobin in efficacy trials. Thus, if those conditions can be replicated in programs or the technology can be adapted to better fit current production and delivery realities, DFS may provide an effective contribution in countries that need additional food-fortification vehicles to improve iron intake.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344565por Pernaute-Lau, Leyre, Morris, Ulrika, Msellem, Mwinyi, Mårtensson, Andreas, Björkman, Anders, Gil, Jose Pedro“…METHODS: Dried blood spots on filter paper were collected from 618 children enrolled in two randomized clinical trials comparing AS–AQ and artemether-lumefantrine in 2002–2005 in Zanzibar. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344566por Datta, Adrija Kumar, Maheshwari, Abha, Felix, Nirmal, Campbell, Stuart, Nargund, Geeta“…OBJECTIVE AND RATIONALE: To evaluate parallel-group randomised controlled trials (RCTs) on IVF where comparisons were made between a mild (≤150 IU daily dose) and conventional stimulation in terms of clinical outcomes and cost-effectiveness in patients described as poor, normal and non-polycystic ovary syndrome (PCOS) hyper-responders to IVF. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344567por Sacco, Simone, Paoletti, Matteo, Staffaroni, Adam M., Kang, Huicong, Rojas, Julio, Marx, Gabe, Goh, Sheng-yang, Luisa Mandelli, Maria, Allen, Isabel E., Kramer, Joel H., Bastianello, Stefano, Henry, Roland G., Rosen, Howie.J., Caverzasi, Eduardo, Geschwind, Michael D.“…Understanding how MRI metrics change over-time, as well as their correlations with clinical deficits are crucial steps in developing radiological biomarkers for trials. Specifically, as mean diffusivity does not change linearly and atrophy mainly occurs in later stages, neither alone is likely to be a sufficient biomarker throughout the disease course. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344568por Zhao, Wanying, Choi, Christopher, Li, Dapeng, Yan, Geqi, Li, Hao, Shi, Zhengxiang“…To ascertain whatever effects different airflow speeds may have on the health of animals kept in stalls located at increasing distances from ventilation fans, we divided a select group of 43 Holstein dairy calves into six subgroups based on age, and each subgroup was subjected to either a specified high-speed or low-speed airflow as follows: (1) Six 3-day-olds received high-speed airflow (D3-HA); (2) Six 3-day-olds received low-speed airflow (D3-LA); (3) Eight 19 (±3)-day-olds received high-speed airflow (D19-HA); (4) Eight 19 (± 3)-day-olds received low-speed airflow (D19-LA); (5) Eight 29 (±3)-day-olds received high-speed airflow (D29-HA); and (6) Seven 29 (±3)-day-olds received medium-speed airflow (D29-MA). These trials show that the rectal temperatures and respiratory rates of D19-LA (39.37 °C; 72.90 breaths/min) were significantly higher than those of D19-HA (39.14 °C; 61.57 breaths/min) (p ≤ 0.05), and those of D29-MA (39.40 °C; 75.52 breaths/min) were significantly higher than those of D29-HA (39.20 °C; 68.41 breaths/min) (p ≤ 0.05). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344569por Ehrlich, Joshua R, Ramke, Jacqueline, Macleod, David, Burn, Helen, Lee, Chan Ning, Zhang, Justine H, Waldock, William, Swenor, Bonnielin K, Gordon, Iris, Congdon, Nathan, Burton, Matthew, Evans, Jennifer R“…In a protocol amendment, we also included randomised controlled trials that met the same criteria as for cohort studies, in which the association between visual impairment and mortality was independent of the study intervention. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344570por Akinosun, Adewale Samuel, Polson, Rob, Diaz - Skeete, Yohanca, De Kock, Johannes Hendrikus, Carragher, Lucia, Leslie, Stephen, Grindle, Mark, Gorely, Trish“…OBJECTIVE: The aim of this study is to identify and measure the effectiveness of digital technology (eg, mobile phones, the internet, software applications, wearables, etc) interventions in randomized controlled trials (RCTs) and determine which behavior change constructs are effective at achieving risk factor modification in patients with CVD. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344571por Chen, Xu‐Qiao, Salehi, Ahmad, Pearn, Matthew L., Overk, Cassia, Nguyen, Phuong D., Kleschevnikov, Alexander M., Maccecchini, Maria, Mobley, William C.“…OBJECTIVE: Recent clinical trials targeting amyloid beta (Aβ) and tau in Alzheimer's disease (AD) have yet to demonstrate efficacy. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344572por Riva, Antonio, Palma, Elena, Devshi, Dhruti, Corrigall, Douglas, Adams, Huyen, Heaton, Nigel, Menon, Krishna, Preziosi, Melissa, Zamalloa, Ane, Miquel, Rosa, Ryan, Jennifer M., Wright, Gavin, Fairclough, Sarah, Evans, Alexander, Shawcross, Debbie, Schierwagen, Robert, Klein, Sabine, Uschner, Frank E., Praktiknjo, Michael, Katzarov, Krum, Hadzhiolova, Tanya, Pavlova, Slava, Simonova, Marieta, Trebicka, Jonel, Williams, Roger, Chokshi, Shilpa“…We believe that anti-TIM3 neutralizing antibodies currently in Phase I clinical trials or soluble-TIM3 should be investigated further for their ability to enhance anti-bacterial immunity. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344573por Gray, Kathryn J., Bordt, Evan A., Atyeo, Caroline, Deriso, Elizabeth, Akinwunmi, Babatunde, Young, Nicola, Baez, Aranxta Medina, Shook, Lydia L., Cvrk, Dana, James, Kaitlyn, De Guzman, Rose, Brigida, Sara, Diouf, Khady, Goldfarb, Ilona, Bebell, Lisa M., Yonker, Lael M., Fasano, Alessio, Rabi, S. Alireza, Elovitz, Michal A., Alter, Galit, Edlow, Andrea G.“…BACKGROUND: Pregnant and lactating women were excluded from initial coronavirus disease 2019 vaccine trials; thus, data to guide vaccine decision making are lacking. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344574por Liu, Bin, Meng, Xiang, Ma, Yanfang, Li, Huizhen, Liu, Yuqi, Shi, Nannan, Chen, Yaolong, Wang, Yanping, Lu, Cheng“…METHODS: PubMed, EMBASE, Web of Science, China Network Knowledge Infrastructure (CNKI), SinoMed and WanFang Data were retrieved for randomized controlled trials (RCTs) and cohort study about TGP adjuvant therapy in patients with RA up to 28 January 2021. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344575Development of expert recommendations for the treatment of PTSD with comorbid substance use disorderpor Roberts, Neil P.“…However, patients with PTSD-SUD comorbidity are often excluded from clinical trials of psychological intervention. Clinicians are therefore often uncertain about how best to implement effective treatment, and traditionally, patients with this comorbidity have been offered treatment sequentially. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344576por Cirocchi, Roberto, Popivanov, Georgi, Konaktchieva, Marina, Chipeva, Sonia, Tellan, Guglielmo, Mingoli, Andrea, Zago, Mauro, Chiarugi, Massimo, Binda, Gian Andrea, Kafka, Reinhold, Anania, Gabriele, Donini, Annibale, Nascimbeni, Riccardo, Edilbe, Mohammed, Afshar, Sorena“…METHODS: A comprehensive systematic search was undertaken to identify all randomized clinical trials (RCTs) and observational studies, irrespectively of their size, publication status, and language. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344577A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitorspor Ghimire, Dibya, KC, Yuvraj, Timilsina, Uddhav, Goel, Kriti, Nitz, T. J., Wild, Carl T., Gaur, Ritu“…Bevirimat (BVM), a highly efficacious first-in-class MI against HIV-1 subtype B isolates, elicited sub-optimal efficacy in clinical trials due to polymorphisms in the CA-SP1 region of the Gag protein (SP1:V7A). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344578“…Therefore, a search was carried out through medical-based online databases including: Cochrane Central, EMBASE, Web of Science, MEDLINE, http://www.ClinicalTrials.gov, and Google scholar for relevant English-based publications. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344579por Tiepolt, Solveig, Becker, Georg-Alexander, Wilke, Stephan, Cecchin, Diego, Rullmann, Michael, Meyer, Philipp M., Barthel, Henryk, Hesse, Swen, Patt, Marianne, Luthardt, Julia, Wagenknecht, Gudrun, Sattler, Bernhard, Deuther-Conrad, Winnie, Ludwig, Friedrich-Alexander, Fischer, Steffen, Gertz, Hermann-Josef, Smits, René, Hoepping, Alexander, Steinbach, Jörg, Brust, Peter, Sabri, Osama“…Overall, (+)-[(18)F]Flubatine showed favorable characteristics and has therefore the potential to serve as α4β2 nAChR–targeting PET ligand in further clinical trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-020-05029-w) contains supplementary material, which is available to authorized users.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344580por Ashton, Nicholas J., Pascoal, Tharick A., Karikari, Thomas K., Benedet, Andréa L., Lantero-Rodriguez, Juan, Brinkmalm, Gunnar, Snellman, Anniina, Schöll, Michael, Troakes, Claire, Hye, Abdul, Gauthier, Serge, Vanmechelen, Eugeen, Zetterberg, Henrik, Rosa-Neto, Pedro, Blennow, Kaj“…Thus, plasma p-tau231 is a promising novel biomarker of emerging AD pathology with the potential to facilitate clinical trials to identify vulnerable populations below PET threshold of amyloid-β positivity or apparent entorhinal tau deposition. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto